TFF Pharmaceuticals Expects To Receive FDA Feedback In Q2 Regarding TFF TAC Clinical Development Plan And Next Steps
TFF Pharmaceuticals Expects To Receive FDA Feedback In Q2 Regarding TFF TAC Clinical Development Plan And Next Steps
TFF Pharmicals預計將在第二季度收到FDA關於TFF TAC臨床開發計劃和後續措施的反饋
TFF Pharmaceuticals Expects To Receive FDA Feedback In Q2 Regarding TFF TAC Clinical Development Plan And Next Steps
TFF Pharmicals預計將在第二季度收到FDA關於TFF TAC臨床開發計劃和後續措施的反饋
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。